De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
IVD Medical Holding Beheer
Beheer criteriumcontroles 4/4
De CEO IVD Medical Holding's is Kuk Sing Ho, benoemd in Jun2019, heeft een ambtstermijn van 5.33 jaar. De totale jaarlijkse vergoeding van { bedraagt CN¥ 3.70M, bestaande uit 99.8% salaris en 0.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 10.8% van de aandelen van het bedrijf, ter waarde HK$ 347.52M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.3 jaar en 3 jaar.
Belangrijke informatie
Kuk Sing Ho
Algemeen directeur
CN¥3.7m
Totale compensatie
| Percentage CEO-salaris | 99.8% |
| Dienstverband CEO | 5.3yrs |
| Eigendom CEO | 10.8% |
| Management gemiddelde ambtstermijn | 5.3yrs |
| Gemiddelde ambtstermijn bestuur | 3yrs |
Recente managementupdates
Recent updates
Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings
Sep 27
IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings
Aug 17Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding
Jun 07These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely
May 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 25IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 03IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings
Mar 30IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year
Mar 20If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity
Mar 06IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Feb 08Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Oct 22IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher
Oct 01IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297
Aug 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 05IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556
Mar 22Returns At IVD Medical Holding (HKG:1931) Are On The Way Up
Feb 16Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?
Oct 16Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)
Sep 28IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet
May 16IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053
Apr 14IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 23IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Mar 16IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital
Jul 30These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well
May 04There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital
Apr 20IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year
Mar 05Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 15
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like
Jan 31A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Jan 16Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?
Jan 01How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?
Dec 17Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?
Dec 02IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.
Nov 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥260m |
| Mar 31 2024 | n/a | n/a | CN¥249m |
| Dec 31 2023 | CN¥4m | CN¥4m | CN¥238m |
| Sep 30 2023 | n/a | n/a | CN¥235m |
| Jun 30 2023 | n/a | n/a | CN¥232m |
| Mar 31 2023 | n/a | n/a | CN¥221m |
| Dec 31 2022 | CN¥5m | CN¥4m | CN¥210m |
| Sep 30 2022 | n/a | n/a | CN¥193m |
| Jun 30 2022 | n/a | n/a | CN¥177m |
| Mar 31 2022 | n/a | n/a | CN¥176m |
| Dec 31 2021 | CN¥4m | CN¥4m | CN¥175m |
Compensatie versus markt: De totale vergoeding ($USD 527.16K ) Kuk Sing } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 410.05K ).
Compensatie versus inkomsten: De vergoeding van Kuk Sing is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Kuk Sing Ho (64 yo)
5.3yrs
Tenure
CN¥3,700,000
Compensatie
Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 5.3yrs | CN¥3.70m | 10.8% CN¥ 347.5m | |
| GM & Executive Director | 5.3yrs | CN¥2.16m | 6.93% CN¥ 223.1m | |
| CFO, Company Secretary & Executive Director | less than a year | geen gegevens | geen gegevens | |
| Executive Director | less than a year | geen gegevens | geen gegevens | |
| Financial Controller | 8.7yrs | geen gegevens | geen gegevens |
5.3yrs
Gemiddelde duur
47yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 1931 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & CEO | 8.4yrs | CN¥3.70m | 10.8% CN¥ 347.5m | |
| GM & Executive Director | 8.8yrs | CN¥2.16m | 6.93% CN¥ 223.1m | |
| CFO, Company Secretary & Executive Director | less than a year | geen gegevens | geen gegevens | |
| Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 5.3yrs | CN¥120.00k | geen gegevens | |
| Independent Non-Executive Director | 5.3yrs | CN¥120.00k | geen gegevens | |
| Non-Executive Director | 3yrs | geen gegevens | geen gegevens | |
| Non-executive Director | less than a year | geen gegevens | geen gegevens |
3.0yrs
Gemiddelde duur
51yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 1931 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).